Skip to content
ANA Investigates ESUS episode artwork

May 11, 2020 14 min

ANA Investigates ESUS

from ANA Investigates Hosted by The American Neurological Association

In this episode, we'll visit the frontiers of vascular neurology, discussing an important but little-understood category of strokes — embolic strokes of undetermined source, or ESUS. We'll hear from Dr. Hooman Kamel, division chief of neurocritical care at Weill Cornell Medicine. Dr. Kamel is a co-principal investigator for the ARCADIA trial, which is testing anti-thrombotic strategies in patients with cryptogenic stroke and atrial cardiopathy. He was interviewed by ANA Member Michelle Johansen, a vascular neurologist and assistant professor of neurology at Johns Hopkins. Series 1, Episode 11

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

ANA Investigates ESUS

0:00 14:24

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of ANA Investigates?

This episode is 14 minutes long.

When was this ANA Investigates episode published?

This episode was published on May 11, 2020.

Can I download this ANA Investigates episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.